Vantage Health Announces Recent Scientific Updates and Corporate Developments
Business Wire - Thu Nov 20, 7:02AM CST
Vantage Health Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company"
Vantage Health enters into strategic partnership with Theranostics Laboratory
M2 - Thu Oct 30, 8:07AM CDT
Vantage Health Inc (OTC:VNTH), a mobile health technology company, announced on Wednesday the entering into a strategic partnership with Theranostics Laboratory, a translational research company.
Vantage Health Forms Strategic Partnership with Theranostics Laboratory
Business Wire - Wed Oct 29, 7:30AM CDT
Vantage Health Inc., (OTCQB:VNTH) ("Vantage Health"
Vantage Health names Edward Rollins to board
M2 - Tue Sep 30, 4:50AM CDT
Vantage Health Inc (OTC: VNTH), a mobile health technology company, announced on Monday that it has appointed Edward Rollins to its board of directors.
Vantage Health Announces Appointment of Edward Rollins, Former Advisor to Four U.S. Presidents, to Its Board of Directors
Business Wire - Mon Sep 29, 7:30AM CDT
Vantage Health Inc., (OTCQB: VNTH) ("Vantage Health" or the "Company"
Vantage Health names Joseph C. Peters to board
M2 - Thu Sep 25, 4:37AM CDT
Vantage Health Inc (OTC:VNTH), a mobile health technology company, announced on Wednesday that it has appointed Joseph C. Peters to its board of directors, effective immediately.
Vantage Health Announces Appointment of Joseph C. Peters, Former White House Drug Policy Office's Acting Deputy Director for State and Local Affairs under Presidents Clinton and Bush, to Its Board of Directors
Business Wire - Wed Sep 24, 7:30AM CDT
Vantage Health Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company"
Vantage Health appoints Dr Steven R. Steinhubl as board chairman
M2 - Wed Sep 24, 6:07AM CDT
Vantage Health Inc (OTC: VNTH), a mobile health technology company, on Tuesday announced that it has appointed Steven R. Steinhubl, MD, as chairman of the board. Dr Steinhubl replaces interim chairman Dr Kevin Buckman, who will remain with the company in an advisory capacity.
Vantage Health Names Dr. Steven R. Steinhubl, Director of Digital Medicine at Scripps Translational Science Institute, New Chairman of the Board
Business Wire - Tue Sep 23, 9:21AM CDT
Vantage Health Inc., (OTCQB:VNTH) ("Vantage Health"
Tony van Bijleveld, General Manager for Patheon/DPX, and Former General Manager Europe for Alliance Boots Walgreens, Appointed to the Vantage Health Board of Directors
Business Wire - Mon Sep 22, 11:20AM CDT
Vantage Health Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company"
Dr Kevin Buckman Named Chairman and CEO of Vantage Health
Business Wire - Tue Jul 29, 2:51PM CDT
Vantage Health (the "Company"
BUYINS.NET Issues Vantage Health SqueezeTrigger Report
M2 - Thu Feb 13, 7:27AM CST
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Vantage Health (OTCBB: VNTH) after releasing the latest short sale data through February 11, 2014. The total aggregate number of shares shorted since March 2011 is approximately 23.35 million shares. Approximately 21.83% of daily trading volume is short selling. The SqueezeTrigger price for all VNTH shares shorted is $0.094. A short squeeze has just begun as shares of VNTH closed above the $0.094 SqueezeTrigger price.